Study of STYLAGE® XXL for Volume Deficiency in the Mid-Face

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The primary objective of the study is to demonstrate the superiority of STYLAGE® XXL versus no treatment at 24 weeks after baseline for the creation or restoration of volume deficit in the mid-face.
Epistemonikos ID: c1a80e2150d34d354ede511163974d3c78a7ca1c
First added on: May 13, 2024